Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2874)
All Articles published online
|
Sep 7, 2010 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen P, Zong L, Zhao W, Shi L. Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors: A meta-analysis. World J Gastroenterol 2010; 16(33): 4227-4232 [PMID: 20806443 DOI: 10.3748/wjg.v16.i33.4227] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i33/4227.htm |
| Number | Citing Articles |
| 1 |
Ling-Jun Song, Hui-Juan Ge, Xiao-Qin Shi, Wei-Wei Shen. Prognostic and predictive values of the KIT11-mutated grading system in patients with gastrointestinal stromal tumors: a retrospective study. Human Pathology 2021; 110: 31 doi: 10.1016/j.humpath.2021.01.001
|
| 2 |
Kevin Wu, Lucas Rodrigues, Gerald Post, Garrett Harvey, Michelle White, Aubrey Miller, Lindsay Lambert, Benjamin Lewis, Christina Lopes, James Zou. Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs. npj Precision Oncology 2023; 7(1) doi: 10.1038/s41698-023-00346-3
|
| 3 |
Zekun Zhao, Jie Zhang, Wenbing Zhang, Siyuan Tan, Hao-tang Wei, Jun You, Shanshan Guo, Jing Wang, Ping Chen, Yingying Xu, Liang Zong. Efficacy evaluation of nilotinib treatment in different genomic subtypes of gastrointestinal stromal tumors: A meta-analysis and systematic review. Current Problems in Cancer 2021; 45(3): 100705 doi: 10.1016/j.currproblcancer.2020.100705
|
| 4 |
Siyuan Tan, Ping Chen, Jiafu Ji, Shanshan Guo, Dapeng Yu, Tetsuya Asakawa, Yu Zhou, Masanobu Abe, Liang Zong. Genomic Subtypes of GISTs for Stratifying Patient Response to Sunitinib following Imatinib Resistance: A Pooled Analysis and Systematic Review. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/1368617
|
| 5 |
Shang Long Liu, Ge Chen, Yu Pei Zhao, Wen Ming Wu, Tai Ping Zhang. Optimized dose of imatinib for treatment of gastrointestinal stromal tumors: A meta‐analysis. Journal of Digestive Diseases 2013; 14(1): 16 doi: 10.1111/1751-2980.12010
|
| 6 |
Yu Zhao, Zuyi Weng, Xuan Zhou, Zhi Xu, Bei Cao, Bin Wang, Juan Li. Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04063-0
|
| 7 |
Alexander Beham, Inga-Marie Schaefer, Silke Cameron, Katharina von Hammerstein, Laszlo Füzesi, Giuliano Ramadori, Michael B. Ghadimi. Duodenal GIST: a single center experience. International Journal of Colorectal Disease 2013; 28(4): 581 doi: 10.1007/s00384-012-1432-8
|
| 8 |
Sebastian Bauer, Michael C. Heinrich, Suzanne George, John R. Zalcberg, César Serrano, Hans Gelderblom, Robin L. Jones, Steven Attia, Gina D'Amato, Ping Chi, Peter Reichardt, Julie Meade, Ying Su, Rodrigo Ruiz-Soto, Jean-Yves Blay, Margaret von Mehren, Patrick Schöffski. Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study. Clinical Cancer Research 2021; 27(23): 6333 doi: 10.1158/1078-0432.CCR-21-1864
|
| 9 |
Lin Yan, Lei Zou, Wenhua Zhao, Yansen Wang, Bo Liu, Hongliang Yao, Haihua Yu. Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis. Scientific Reports 2015; 5(1) doi: 10.1038/srep13718
|
| 10 |
Yasemin Baskin, Gizem Calibasi Kocal, Betul Bolat Kucukzeybek, Mahdi Akbarpour, Nurcin Kayacik, Ozgul Sagol, Hulya Ellidokuz, Ilhan Oztop. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 24(1): 41 doi: 10.3727/096504016X14576297492418
|
| 11 |
Xiaofei Zhi, Xiaoying Zhou, Weizhi Wang, Zekuan Xu, Ajay Goel. Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis. PLoS ONE 2013; 8(11): e79275 doi: 10.1371/journal.pone.0079275
|
| 12 |
Nour Pharaon, Wafa Habbal, Fawza Monem. Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed. Journal of the Egyptian National Cancer Institute 2023; 35(1) doi: 10.1186/s43046-023-00185-0
|
| 13 |
Piotr Rutkowski, Jolanta Andrzejuk, Elżbieta Bylina, Czesław Osuch, Tomasz Świtaj, Anna Jerzak vel Dobosz, Urszula Grzesiakowska, Monika Jurkowska, Agnieszka Woźniak, Janusz Limon, Maria Dębiec-Rychter, Janusz A. Siedlecki. What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?. Medical Oncology 2013; 30(4) doi: 10.1007/s12032-013-0765-7
|
| 14 |
Shin Miura, Kiyoshi Kume, Shin Hamada, Atsushi Kanno, Jun Unno, Kazuhiro Kikuta, Morihisa Hirota, Atsushi Masamune, Tooru Shimosegawa. Multiple Gastrointestinal Stromal Tumors Associated with Neurofibromatosis Type I Preoperatively Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration: Report of a Case and Review of Literature. Nihon Naika Gakkai Zasshi 2012; 101(12): 3510 doi: 10.2169/naika.101.3510
|
| 15 |
Wen-Kuan Huang, Hao Shi, Pinar Akçakaya, Katarina Zeljic, Anastasia Gangaev, Stefano Caramuta, Chun-Nan Yeh, Robert Bränström, Catharina Larsson, Weng-Onn Lui. Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences 2021; 22(19): 10600 doi: 10.3390/ijms221910600
|
| 16 |
LIANG ZONG, PING CHEN, JIAN JIANG, LEI WANG, QING GUO LI. Predictive value of p53 expression in the risk of malignant gastrointestinal stromal tumors: Evidence from 19 studies. Experimental and Therapeutic Medicine 2012; 3(1): 87 doi: 10.3892/etm.2011.369
|
| 17 |
Liang Zong, Ping Chen. Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World Journal of Surgical Oncology 2014; 12(1): 71 doi: 10.1186/1477-7819-12-71
|